EUVIMEDEUVIMED entdecken
Leserbrief

Interpreting isotretinoin dosing trials: Age, duration and statistical power

Constantinos D Verros iD, Efstathios A Rallis iD

Journal of the European Academy of Dermatology and Venereology · 07.11.2026

DOI: 10.1111/jdv.70844 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 07.11.2026. Verfasst von Constantinos D Verros und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Dermatology Practice, Tripoli, Greece. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acne vulgarisadolescencecumulative doseisotretinoinrandomized controlled trialrelapse

Autor:innen und Institutionen

  • Private Dermatology Practice, Tripoli, Greece.
  • Department of Biomedical Sciences, University of West Attica, Athens, Greece.

ORCID-Profile: Constantinos D Verros, Efstathios A Rallis

Zitieren

APA

Verros, C. D., & Rallis, E. A. (2026). Interpreting isotretinoin dosing trials: Age, duration and statistical power. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70844

Vancouver

Verros CD, Rallis EA. Interpreting isotretinoin dosing trials: Age, duration and statistical power. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70844

BibTeX
@article{Verros2026,
  author = {Verros, Constantinos D and Rallis, Efstathios A},
  title = {Interpreting isotretinoin dosing trials: Age, duration and statistical power},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  doi = {10.1111/jdv.70844}
}
Kostenlos starten →